Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co ElifiledCriticalLilly Co Eli
Publication of DOP2019000082ApublicationCriticalpatent/DOP2019000082A/en
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
Peptides Or Proteins
(AREA)
Abstract
La presente invención proporciona anticuerpos los cuales se unen y neutralizan IL-33 humano, y métodos para usar los mismos, tales anticuerpos son útiles como agentes para el tratamiento de condiciones asociadas con enfermedad alérgica que incluye tratar dermatitis atópica.The present invention provides antibodies which bind and neutralize human IL-33, and methods for using them, such antibodies are useful as agents for the treatment of conditions associated with allergic disease that includes treating atopic dermatitis.
DO2019000082A2017-10-292019-04-02
ANTI-IL-33 ANTIBODIES AND USES OF THE SAME
DOP2019000082A
(en)